Search clinical trials for: Docetaxel (XRP6976)

Total 2265 results

OHSU Knight Cancer Institute

Completed

Docetaxel in Treating Patients With Stage IV Prostate Cancer

Pain | Prostate Cancer

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal Junction

Gastric Cancer | Esophageal Cancer

United States
Hoffmann-La Roche

Completed

XEBRA Study: An Observational Study of Xeloda (Capecitabine) in Combination With Docetaxel in First Line in Participants With HER2-Negative Metastatic Breast Cancer

Breast Cancer

Hungary
BIND Therapeutics

Completed

A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer

Squamous Cell Non-small Cell Lung Cancer | KRAS Positive Patients With Non-small Cell Lung Cancer

United States, Russian Federation
BIND Therapeutics

Terminated

A Study of BIND-014 in Patients With Urothelial Carcinoma, Cholangiocarcinoma, Cervical Cancer and Squamous Cell Carcinoma of the Head and Neck (iNSITE2)

Cervical Cancer | Squamous Cell Carcinoma of Head and Neck | Cholangiocarcinoma | Urothelial Carcinoma

Russian Federation, United States
Indiana University School of Medicine
Aventis Pharmaceuticals

Completed

Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer

Breast Cancer

United States
Wakayama Medical University

Unknown

Trial of Docetaxel, Cisplatin, Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

Esophageal Cancer

Japan
Cancer Trials Ireland

Completed

A Phase II Neo-adjuvant Study Assessing TCH (Docetaxel, Carboplatin and Trastuzumab) and TCHL (Docetaxel, Carboplatin, Trastuzumab and Lapatinib) in HER-2 Positive Breast Cancer Patients. (TCHL Phase II)

Breast Cancer

Ireland
Sanofi

Completed

GILT Docetaxel - Non-Small Cell Lung Cancer

Lung Neoplasms

Spain, Germany, Switzerland
Azienda Ospedaliero-Universitaria Careggi

Completed

Predictive fActors for toleraNce to Taxane Based CHemotherapy In Older adultS Affected by mEtastatic Prostate Cancer (ANCHISES)

Metastatic Prostate Cancer | Elderly Patients

Italy
Shandong Cancer Hospital and Institute
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Unknown

A Trial of Anlotinib Combined With Docetaxel in EGFR Mutations Advanced Non Small Cell Lung Cancer Patients

Non Small Cell Lung Cancer

China
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

Breast Cancer

United States
Yonsei University

Completed

A Study to Evaluate the Efficacy of Docetaxel and Carboplatin in Metastatic Malignant Melanoma Failed First-Line Dacabazine or Temozolomide Contained Therapy

Malignant Melanoma

Korea, Republic of
Aventis Pharmaceuticals

Completed

Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer

Breast Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Withdrawn

S0217, Adjuvant Cisplatin and Docetaxel After Complete Resection Stage III or IV Head and Neck Cancer (S0217)

Head and Neck Cancer

United States
Fudan University

Terminated

Study of Weekly DCF to Treat Advanced Gastric Cancer

Gastric Cancer

China
Sun Yat-sen University

Recruiting

Targeted or Chemotherapy Combined With Immunotherapy Versus Chemotherapy for PD-1 Inhibitor Refractory R/M NPC

Nasopharyngeal Carcinoma

China
Modra Pharmaceuticals

Withdrawn

Absorption and Excretion of Oral Docetaxel

Solid Tumor, Adult

Netherlands
Modra Pharmaceuticals

Completed

ModraDoc006/r in Patients With Breast Cancer

Metastatic Breast Cancer | Recurrent Breast Cancer

Denmark, Belgium, Spain
Modra Pharmaceuticals
The Netherlands Cancer Institute

Completed

ModraDoc006/r in Metastatic Castration-resistant Prostate Cancer

Castration-resistant Prostate Cancer

Netherlands
Swiss Group for Clinical Cancer Research

Completed

Combination Chemotherapy Followed by Surgery in Treating Patients With Non-small Cell Lung Cancer

Lung Cancer

Switzerland
Biotech Pharmaceutical Co., Ltd.

Terminated

Nimotuzumab Plus Docetaxel in Chemotherapy-Refractory/Resistant Patients With Advanced Non-Small-Cell Lung Cancer

Advanced Non-Small Cell Lung Cancer

China
Memorial Sloan Kettering Cancer Center
Oncology/Hematology West

Completed

Docetaxel + Cetuximab + Concurrent Re-Irradiation (Intensity - Modulated Radiation Therapy, IMRT) for Patients With Locoregionally Recurrent Head and Neck Cancer

Head and Neck Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0027: Vinorelbine Followed by Docetaxel in Treating Patients With Advanced Non-Small Cell Lung Cancer

Lung Cancer

United States
Southwest Oncology Group
National Cancer Institute (NCI)

Completed

S0102: Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer

Breast Cancer

United States
Chonnam National University Hospital
Chungbuk National University; Chungnam National University; Chonbuk National...

Completed

Docetaxel, Cisplatin, and S-1 (TPS) Induction Chemotherapy in Locally Advanced Head and Neck Cancer (TPSHNSCC)

Head and Neck Cancer

Korea, Republic of
European Organisation for Research and Treatment...

Completed

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Breast Cancer

France, Belgium
Abbott
Genentech, Inc.

Completed

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Solid Tumor

United States, Netherlands, United Kingdom
Samsung Medical Center

Completed

Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer

Advanced Gastric Cancer

Korea, Republic of
Taipei Medical University Hospital
Pfizer; TTY Biopharm

Unknown

Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Taiwan
Roswell Park Cancer Institute
National Cancer Institute (NCI)

Completed

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Zhao Chong
Wu Jieping Medical Foundation

Active, not recruiting

The Function of PA, RBP and TRSF in Malnutrition Detecting and Nutritional Status Monitoring for NPC Patients

Nasopharyngeal Carcinoma | Malnutrition

China
Modra Pharmaceuticals

Completed

Extended Use of ModraDoc006/r

Advanced Solid Tumours

Netherlands
Tianjin Medical University Cancer Institute and...

Unknown

Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

Squamous Cell Lung Cancer

China
Sanofi

Completed

Dose Escalation, Safety and Pharmacokinetic Study of AVE8062 Combined With Docetaxel and Cisplatin in Patients With Solid Tumors

Neoplasms, Malignant

Japan
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI)

Completed

Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer

Breast Cancer

United States
Charite University, Berlin, Germany
Sanofi; Roche Pharma AG

Unknown

Study to Evaluate Safety and Efficacy of Perioperative Chemotherapy With Docetaxel, Cisplatin and Capecitabine (DCX) in Patients With Gastro-esophageal Cancer (DCXAIOCHARITE)

Gastric Cancer | Esophageal Cancer

Germany
Oncology Specialties, Alabama

Terminated

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma

Metastatic Breast Cancer

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Radiation Therapy and Docetaxel in Treating Patients With HPV-Related Oropharyngeal Cancer

Human Papillomavirus Infection | Stage IVA Oropharyngeal Squamous Cell Carcinoma | Stage IVB Oropharyngeal Squamous Cell Carcinoma | Stage I Oropharyngeal Squamous Cell Carcinoma | Stage II Oropharyngeal Squamous Cell Carcinoma | Stage III Oropharyngeal Squamous Cell Carcinoma

United States
OHSU Knight Cancer Institute
National Cancer Institute (NCI); The Wayne D. Kuni and Joan E. Kuni Foundation

Terminated

Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel

Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Metastatic Prostatic Adenocarcinoma | Hormone-Resistant Prostate Cancer

United States
BeyondSpring Pharmaceuticals Inc.

Completed

Docetaxel + Plinabulin Compared to Docetaxel + Placebo in Patients With Advanced NSCLC (DUBLIN-3)

Non-Small Cell Lung Cancer

United States, China, Australia
Samsung Medical Center

Completed

Neoadjuvant Chemotherapy for Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)

Hypopharyngeal Cancer

Korea, Republic of
McGill University

Completed

Pilot Study of Perioperative Docetaxel, Oxaliplatin, and 5-Fluorouracil (FLOT) in Gastroesophageal Adenocarcinoma

Gastric Adenocarcinoma | Esophageal Adenocarcinoma

Canada
National University Hospital, Singapore

Completed

A Phase II Study of Docetaxel Plus Carboplatin in Chemonaive Hormone-Refractory Prostate Cancer (HRPC) Patients

Hormone-Refractory Prostate Cancer

Singapore
Tufts Medical Center

Withdrawn

Cyclophosphamide and Docetaxel Every 3 Weeks as Neoadjuvant Therapy in Locally Advanced Breast Cancer

Breast Cancer
Taipei Medical University Hospital

Completed

Salvage Therapy With Bevacizumab Plus Docetaxel and Cisplatin for Taiwanese Metastatic Breast Cancer

Metastatic Breast Cancer

Taiwan
Dokuz Eylul University

Not yet recruiting

Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer Patients

Bladder Cancer | Gemcitabine | BCG | Docetaxel | Intravesical Instillation

Turkey
Modra Pharmaceuticals
The Netherlands Cancer Institute

Completed

Food Effect Study of ModraDoc006 in Combination With Ritonavir

Solid Tumor, Adult

Netherlands
University of Southern California

Withdrawn

Cancer Treatment Followed by Surgery for Early Stage Non-small Cell Lung Cancer

Lung Cancer
Memorial Sloan Kettering Cancer Center

Completed

Chemotherapy in Treating Patients With Solid Tumors

Kidney Cancer | Breast Cancer | Head and Neck Cancer | Colorectal Cancer | Esophageal Cancer | Ovarian Cancer | Lung Cancer | Prostate Cancer | Unspecified Adult Solid Tumor, Protocol Specific | Bladder Cancer

United States

Search clinical trials for: Docetaxel (XRP6976)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations